PT3165222T - Utilização do composto de ftalida - Google Patents

Utilização do composto de ftalida

Info

Publication number: PT3165222T
Authority: PT; Portugal
Prior art keywords: phthalide compound; phthalide; compound
Prior art date: 2014-07-04

Application number

PT148969470T

Other languages

English (en)

Original Assignee

Everfront Biotech Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2014-07-04

Filing date

2014-07-04

Publication date

2020-05-14

2014-07-04 Application filed by Everfront Biotech Inc filed Critical Everfront Biotech Inc

2020-05-14 Publication of PT3165222T publication Critical patent/PT3165222T/pt

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/365—Lactones
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Neurosurgery (AREA)
Medicinal Chemistry (AREA)
Neurology (AREA)
Biomedical Technology (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
Chemical & Material Sciences (AREA)
Public Health (AREA)
Chemical Kinetics & Catalysis (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Psychology (AREA)
Hospice & Palliative Care (AREA)
Psychiatry (AREA)
Epidemiology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

PT148969470T 2014-07-04 2014-07-04 Utilização do composto de ftalida PT3165222T (pt)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
PCT/CN2014/081678 WO2016000265A1 (zh)	2014-07-04	2014-07-04	苯酞化合物的应用
EP14896947.0A EP3165222B1 (en)	2014-07-04	2014-07-04	Use of phthalide compound

Publications (1)

Publication Number	Publication Date
PT3165222T true PT3165222T (pt)	2020-05-14

Family

ID=55018341

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
PT148969470T PT3165222T (pt)	2014-07-04	2014-07-04	Utilização do composto de ftalida

Country Status (7)

Country	Link
EP (1)	EP3165222B1 (pt)
JP (1)	JP6413008B2 (pt)
AU (1)	AU2014399624B2 (pt)
ES (1)	ES2795696T3 (pt)
NZ (1)	NZ728386A (pt)
PT (1)	PT3165222T (pt)
WO (1)	WO2016000265A1 (pt)

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JP2002068973A (ja) *	2000-06-16	2002-03-08	Meiji Milk Prod Co Ltd	幹細胞分化誘導促進剤
US7416747B2 (en) *	2000-11-22	2008-08-26	Xia Yongchao	Herbal composition for treatment of neurodegeneration and neuronal dysfunction
EP1437410A4 (en) *	2001-09-13	2005-01-26	Juridical Foundation	NEW SELENOCYSTEIN CONTAINING PROTEINS
JP4953041B2 (ja) *	2001-09-19	2012-06-13	株式会社フジモト・コーポレーション	アポトーシス抑制剤
CN100435792C (zh) *	2004-04-23	2008-11-26	石药集团中奇制药技术（石家庄）有限公司	丁基苯酞类同系物在制备治疗抗血小板聚集和抗血栓药物中的应用
CN101455661B (zh) *	2008-11-19	2012-10-10	中国科学院上海有机化学研究所	3-取代苯酞及其类似物的用途
ES2522167T3 (es) *	2010-01-05	2014-11-13	National Dong Hwa University	Formulación anticancerosa
TWI386203B (zh) *	2011-01-07	2013-02-21	Univ China Medical	治療腦癌或用以降低腦癌細胞對替莫唑胺之抗藥性之醫藥組合物及其應用
JP6087706B2 (ja) *	2012-04-12	2017-03-01	クラシエ製薬株式会社	細胞死抑制組成物
EP2992879B1 (en) *	2012-08-17	2017-12-06	China Medical University	Pharmaceutical composition for inhibiting autophagy of motor neurons and use thereof

2014
- 2014-07-04 JP JP2017500053A patent/JP6413008B2/ja active Active
- 2014-07-04 PT PT148969470T patent/PT3165222T/pt unknown
- 2014-07-04 WO PCT/CN2014/081678 patent/WO2016000265A1/zh active Application Filing
- 2014-07-04 NZ NZ728386A patent/NZ728386A/en unknown
- 2014-07-04 EP EP14896947.0A patent/EP3165222B1/en active Active
- 2014-07-04 ES ES14896947T patent/ES2795696T3/es active Active
- 2014-07-04 AU AU2014399624A patent/AU2014399624B2/en active Active

Also Published As

Publication number	Publication date
EP3165222B1 (en)	2020-03-11
JP6413008B2 (ja)	2018-10-24
NZ728386A (en)	2018-02-23
ES2795696T3 (es)	2020-11-24
WO2016000265A1 (zh)	2016-01-07
AU2014399624B2 (en)	2018-06-28
JP2017521417A (ja)	2017-08-03
EP3165222A4 (en)	2018-01-10
EP3165222A1 (en)	2017-05-10
AU2014399624A1 (en)	2017-02-09

Publication	Publication Date	Title
ZA201700880B (en)	2020-01-29	Polymorphs of selinexor
SG11201706729SA (en)	2017-09-28	Derivatives of sobetirome
IL248991A0 (en)	2017-01-31	Converted dihydroisoquinolinone compounds
SG11201609265RA (en)	2016-12-29	Characterizing states of subject
AP2017009836A0 (en)	2017-03-31	Aminopyridyloxypyrazole compounds
SI3845221T1 (sl)	2024-03-29	Trdne oblike sofosbuvirja
PT3113773T (pt)	2019-11-12	Formas cristalinas do grapiprant
IL246979A0 (en)	2016-09-29	Crystalline forms of sofosbuvir
ZA201706282B (en)	2019-01-30	Solid forms of menaquinols
AP2017009778A0 (en)	2017-03-31	Azetidinyloxyphenylpyrrolidine compounds
IL249130B (en)	2018-12-31	Preparation of piperidine-4-carbothioamide
GB201407822D0 (en)	2014-06-18	Use of a composition
HUP1500506A2 (en)	2017-07-28	Salts of palbociclib
PL3131633T3 (pl)	2020-08-24	Pochodne MMF etylenoglikoli
PT3165222T (pt)	2020-05-14	Utilização do composto de ftalida
IL249332A0 (en)	2017-02-28	Crystalline forms of sofosbuvir
PL3137475T3 (pl)	2019-01-31	Oczyszczanie epidaunorubicyny
GB201418230D0 (en)	2014-11-26	Construction of surfaces
TWM490331U (en)	2014-11-21	Improved structure of mask
GB201412359D0 (en)	2014-08-27	Composition of objects
GB201412089D0 (en)	2014-08-20	Composition of objects
GB201402924D0 (en)	2014-04-02	The theory of instantransmission
GB201404705D0 (en)	2014-04-30	Theory of Conceptual art
GB201403170D0 (en)	2014-04-09	Preparation of antibacterial bisbenzimidazoles
GB201401784D0 (en)	2014-03-19	Compounds